23Andme Holding Co

Company Profile

23Andme Holding Co had its IPO on 2020-11-23 under the ticker symbol ME.

The company operates in the Healthcare sector and Diagnostics & Research industry. 23Andme Holding Co has a staff strength of 758 employees.

Stock update

Shares of 23Andme Holding Co opened at $1.12 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.08 - $1.14, and closed at $1.12.

This is a -1.75% slip from the previous day's closing price.

A total volume of 2,894,557 shares were traded at the close of the day’s session.

In the last one week, shares of 23Andme Holding Co have increased by 0%.

23Andme Holding Co's Key Ratios

23Andme Holding Co has a market cap of $529.19 million, indicating a price to book ratio of 1.7123 and a price to sales ratio of 4.1168.

In the last 12-months 23Andme Holding Co’s revenue was $295.84 million with a gross profit of $132.95 million and an EBITDA of $-308883008. The EBITDA ratio measures 23Andme Holding Co's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, 23Andme Holding Co’s operating margin was -114.75% while its return on assets stood at -21.95% with a return of equity of -42.72%.

In Q2, 23Andme Holding Co’s quarterly earnings growth was a positive 0% while revenue growth was a negative 5.7%.

23Andme Holding Co’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.7 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into 23Andme Holding Co’s profitability.

23Andme Holding Co stock is trading at a EV to sales ratio of 3.6082 and a EV to EBITDA ratio of -3.7245. Its price to sales ratio in the trailing 12-months stood at 4.1168.

23Andme Holding Co stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$871.20 million

Total Liabilities

$118.91 million

Operating Cash Flow

$-2695000.00

Capital Expenditure

$2.70 million

Dividend Payout Ratio

0%

23Andme Holding Co ended 2024 with $871.20 million in total assets and $0 in total liabilities. Its intangible assets were valued at $871.20 million while shareholder equity stood at $675.49 million.

23Andme Holding Co ended 2024 with $0 in deferred long-term liabilities, $118.91 million in other current liabilities, 47000.00 in common stock, $-1611008000.00 in retained earnings and $351.74 million in goodwill. Its cash balance stood at $314.35 million and cash and short-term investments were $314.35 million. The company’s total short-term debt was $7,823,000 while long-term debt stood at $0.

23Andme Holding Co’s total current assets stands at $360.28 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $4.12 million compared to accounts payable of $12.75 million and inventory worth $11.82 million.

In 2024, 23Andme Holding Co's operating cash flow was $-2695000.00 while its capital expenditure stood at $2.70 million.

Comparatively, 23Andme Holding Co paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$1.12

52-Week High

$3.5

52-Week Low

$0.987

Analyst Target Price

$4.5

23Andme Holding Co stock is currently trading at $1.12 per share. It touched a 52-week high of $3.5 and a 52-week low of $3.5. Analysts tracking the stock have a 12-month average target price of $4.5.

Its 50-day moving average was $1.5 and 200-day moving average was $2.09 The short ratio stood at 10.71 indicating a short percent outstanding of 0%.

Around 500% of the company’s stock are held by insiders while 4665.4% are held by institutions.